NUSAJAYA: The Johor government has allocated RM150 million to upgrade and widen village roads through Infra Desa Johor (IDJ) from February 2012 to January next year, said state Public Works and Rural and Regional Development Committee chairman Hasni Mohammad.
“IDJ did not widen or upgrade any road from 2010 to 2011 because its existing scope of work was only to carry out road maintenance,” he said in reply to a question from Aminolhuda Hassan (Pas-Parit Yaani) at the Second Meeting (Budget 2015) of the Second Term of the 13th Johor State Assembly, here, today.
He said since September, the progress of work done was worth RM143 million, which was 95 per cent of the allocation spent involving 1,100 km of road.
“It is expected that IDJ will be able to complete repairs and upgrades on 1,121 km of road until January 2015.
“From the 1,121 km, widening will be done on 514.11 km which is 46 per cent of the total road being upgraded,” he said.
To a question from Mohammad Taslim (PAS-Maharani), he said roads which were tarred in Maharani using funds from Marris (Malaysian Road Records Information System) in 2012 involved 11 roads, 12 roads in 2013 and nine roads in 2014.
“Jalan Kampung Parit Samsu is included in the list of works done in 2012 and 2013. Jalan Kampung Parit Samsu has been repaired several times through the allocation from Marris.
“According to records since 2012, this road has been repaired twice but the same problem recurs. Based on our visual site investigation, the road edge’s weak structure is the main cause of the damage,” he added.
Source: www.freemalaysiatoday.com/
Wednesday 19 November 2014
Saturday 15 November 2014
INDIA’S Biocon invests US$ 200 million to make insulin in Johor
INDIA’S biggest biopharmaceutical company Biocon Ltd, which is investing US$200 million (RM668 million) to make insulin in Johor, is joining hands with Chemical Company of Malaysia Bhd (CCM) to sell Insugen in Malaysia early next year.
The state-of-the-art integrated manufacturing facility in Johor is set to boost Bangalore-based Biocon’s production capacity and make it the world’s third largest insulin supplier.
“We started construction on the Malaysian project in mid-2012 and are in the final stages of wrapping up Phase 1 of the project. We have already pumped in US$160 million into the venture,” said Biocon president of marketing, Ravi Limaye.
“Once Phase 1 is operational in the next few months and depending on matching capacity requirements, which are subject to regulatory approvals, we will invest an additional US$40 million in developing Phase 2,” Ravi added.
Health Ministry statistics show that around three million Malaysian adults suffer from diabetes.
“The partnership with Biocon is expected to bring value to Malaysia’s RM70 million insulin market,” said CCM acting chief executive officer Leonard Ariff Abdul Shatar.
Minister in the Prime Minister’s Department Datuk Seri Idris Jala, who officiated at the launch of Biocon’s Insugen and Insupen products, here, yesterday, said Malaysia was heavily reliant on imported generic and patented drugs.
Expensive drugs tend to be out of reach for the lower-income households.
Idris lauded Biocon and CCM’s tie-up in supplying generic drugs in the form of biosimilar insulin, saying they were priced affordably and just as effective as patented ones.
Leonard noted that the collaboration with Biocon was accelerating the group’s foray into biosimilars.
In established markets such as the United States and Europe, Novo Nordisk, Sanofi and Eli Lilly enjoy exclusive marketing rights for their insulin products due to strictly enforced intellectual property laws.
As soon as the patents expire, it opens the doors for biosimilar insulins, which are second- generation “copies” of the original insulin products.
Leonard said biosimilars were developed using the same genetic contents and were designed to have the same mechanism of action as the original in terms of safety and efficacy, but priced more affordably.
The state-of-the-art integrated manufacturing facility in Johor is set to boost Bangalore-based Biocon’s production capacity and make it the world’s third largest insulin supplier.
“We started construction on the Malaysian project in mid-2012 and are in the final stages of wrapping up Phase 1 of the project. We have already pumped in US$160 million into the venture,” said Biocon president of marketing, Ravi Limaye.
“Once Phase 1 is operational in the next few months and depending on matching capacity requirements, which are subject to regulatory approvals, we will invest an additional US$40 million in developing Phase 2,” Ravi added.
Health Ministry statistics show that around three million Malaysian adults suffer from diabetes.
“The partnership with Biocon is expected to bring value to Malaysia’s RM70 million insulin market,” said CCM acting chief executive officer Leonard Ariff Abdul Shatar.
Minister in the Prime Minister’s Department Datuk Seri Idris Jala, who officiated at the launch of Biocon’s Insugen and Insupen products, here, yesterday, said Malaysia was heavily reliant on imported generic and patented drugs.
Expensive drugs tend to be out of reach for the lower-income households.
Idris lauded Biocon and CCM’s tie-up in supplying generic drugs in the form of biosimilar insulin, saying they were priced affordably and just as effective as patented ones.
Leonard noted that the collaboration with Biocon was accelerating the group’s foray into biosimilars.
In established markets such as the United States and Europe, Novo Nordisk, Sanofi and Eli Lilly enjoy exclusive marketing rights for their insulin products due to strictly enforced intellectual property laws.
As soon as the patents expire, it opens the doors for biosimilar insulins, which are second- generation “copies” of the original insulin products.
Leonard said biosimilars were developed using the same genetic contents and were designed to have the same mechanism of action as the original in terms of safety and efficacy, but priced more affordably.
Source: http://www.malaysia-chronicle.com/
Saturday 8 November 2014
Johor upbeat of achieving investments worth RM20bil this year
PASIR GUDANG: The Johor government is upbeat about achieving an investment figure of more than RM20 billion this year, compared to RM14.4 billion in 2013.
State Tourism, Domestic Trade and Consumerism Committee chairman Datuk Tee Siew Kiong said the optimism is based on the steady increase of foreign investment to the state.
He said the state received investment totalling RM18.7 billion in the first seventh months of the year.
Tee revealed that there is a foreign multinational company that is showing keen interest in investing in Johor.
"Talks with the international company is now in its final phase, and the state government is confident the investment worth about RM6 billion will soon pour into the Sedenak Industrial Park in Kulai.
"Based on the new development, the state government is confident the total investment this year will reach more than RM20 billion, and this will propel Johor as the highest investment state in the country.
"We found that the manufacturing sector is a strong contributor to the economic development of Johor, contributing nearly 35 per cent to the Gross Domestic Product of the state," he said after opening the Langsat Bitumen Terminal in Tanjung Langsat here today.
Source: http://www.nst.com.my/node/50197
State Tourism, Domestic Trade and Consumerism Committee chairman Datuk Tee Siew Kiong said the optimism is based on the steady increase of foreign investment to the state.
He said the state received investment totalling RM18.7 billion in the first seventh months of the year.
Tee revealed that there is a foreign multinational company that is showing keen interest in investing in Johor.
"Talks with the international company is now in its final phase, and the state government is confident the investment worth about RM6 billion will soon pour into the Sedenak Industrial Park in Kulai.
"Based on the new development, the state government is confident the total investment this year will reach more than RM20 billion, and this will propel Johor as the highest investment state in the country.
"We found that the manufacturing sector is a strong contributor to the economic development of Johor, contributing nearly 35 per cent to the Gross Domestic Product of the state," he said after opening the Langsat Bitumen Terminal in Tanjung Langsat here today.
Source: http://www.nst.com.my/node/50197
Subscribe to:
Posts (Atom)